Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1983 Apr;50:27–36. doi: 10.1289/ehp.835027

Two-generation saccharin bioassays.

D L Arnold
PMCID: PMC1569221  PMID: 6347682

Abstract

The controversy regarding the safety of saccharin for human consumption started shortly after its discovery over 100 years ago and has yet to subside appreciably. The consumption of saccharin, particularly in North America, began to escalate when the U.S. Food and Drug Administration set new standards of identity which allowed foods containing artificial sweeteners to be promoted as "nonnutritive" or "noncaloric" sweeteners for use by the general public. In 1969, when cyclamates were banned, at least 10 single-generation feeding studies were undertaken with saccharin to more accurately assess the potential toxicological consequences resulting from the anticipated increase in its consumption. None of these studies resulted in any overt regulatory action. Subsequently, the introduction of the two-generation chronic toxicity/carcinogenicity bioassay added a new tool to the toxicologist's arsenal. Three two-generation studies using saccharin have since been conducted. The results from these studies clearly show that when rats were exposed to diets containing 5 or 7.5% sodium saccharin from the time of conception to death, an increased frequency of urinary bladder cancers was found, predominantly in the males. While some study results suggested that impurities in commercial saccharin or the presence of urinary tract calculi may have been responsible for the observed bladder tumors, it now appears that these possibilities are highly unlikely. The mechanism by which saccharin elicited the bladder tumors using the two-generation experiment has not been ascertained.

Full text

PDF
27

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong B., Doll R. Bladder cancer mortality in diabetics in relation to saccharin consumption and smoking habits. Br J Prev Soc Med. 1975 Jun;29(2):73–81. doi: 10.1136/jech.29.2.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arnold D. L., Charbonneau S. M., Zawidzka Z. Z., Grice H. C. Monitoring animal health during chronic toxicity studies. J Environ Pathol Toxicol. 1977 Nov-Dec;1(2):227–239. [PubMed] [Google Scholar]
  3. Arnold D. L., Moodie C. A., Grice H. C., Charbonneau S. M., Stavric B., Collins B. T., McGuire P. F., Zawidzka Z. Z., Munro I. C. Long-term toxicity of ortho-touenesulfonamide and sodium saccharin in the rat. Toxicol Appl Pharmacol. 1980 Jan;52(1):113–152. doi: 10.1016/0041-008x(80)90253-7. [DOI] [PubMed] [Google Scholar]
  4. Arnold D. L., Moodie C. A., McGuire P. F., Collins B. T., Charbonneau S. M., Munro I. C. The effect of ortho toluenesulfonamide and sodium saccharin on the urinary tract of neonatal rats. Toxicol Appl Pharmacol. 1979 Dec;51(3):455–463. doi: 10.1016/0041-008x(79)90370-3. [DOI] [PubMed] [Google Scholar]
  5. Ashby J., Styles J. A., Anderson D., Paton D. Saccharin: an epigenetic carcinogen/mutagen? Food Cosmet Toxicol. 1978 Apr;16(2):95–103. doi: 10.1016/s0015-6264(78)80187-4. [DOI] [PubMed] [Google Scholar]
  6. Ball L. M., Renwick A. G., Williams R. T. The fate of [14C]saccharin in man, rat and rabbit and of 2-sulphamoyl[14C]benzoic acid in the rat. Xenobiotica. 1977 Apr;7(4):189–203. doi: 10.3109/00498257709035778. [DOI] [PubMed] [Google Scholar]
  7. Byard J. L., Goldberg L. The metabolism of saccharin in laboratory animals. Food Cosmet Toxicol. 1973 Jun;11(3):391–402. doi: 10.1016/0015-6264(73)90005-9. [DOI] [PubMed] [Google Scholar]
  8. Byard J. L., McChesney E. W., Golberg L., Coulston F. Excretion and metabolism of saccharin in man. II. Studies with 14-C-labelled and unlabelled saccharin. Food Cosmet Toxicol. 1974 Apr;12(2):175–184. doi: 10.1016/0015-6264(74)90362-9. [DOI] [PubMed] [Google Scholar]
  9. Clayson D. B. Editorial: Bladder carcinogenesis in rats and mice: possibility of artifacts. J Natl Cancer Inst. 1974 Jun;52(6):1685–1689. doi: 10.1093/jnci/52.6.1685. [DOI] [PubMed] [Google Scholar]
  10. FITZHUGH O. G., NELSON A. A., FRAWLEY J. P. A comparison of the chronic toxicities of synthetic sweetening agents. J Am Pharm Assoc Am Pharm Assoc. 1951 Nov;40(11):583–586. doi: 10.1002/jps.3030401117. [DOI] [PubMed] [Google Scholar]
  11. Flaks A., Clayson D. B. The influence of ammonium chloride on the induction of bladder tumours by 4-ethylsulphonylnaphthalene-1-sulphonamide. Br J Cancer. 1975 May;31(5):585–587. doi: 10.1038/bjc.1975.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fox J. G., Thibert P., Arnold D. L., Krewski D. R., Grice H. C. Toxicology studies. II. The laboratory animal. Food Cosmet Toxicol. 1979 Dec;17(6):661–675. doi: 10.1016/0015-6264(79)90127-5. [DOI] [PubMed] [Google Scholar]
  13. Friedman L. Symposium on the evaluation of the safety of food additives and chemical residues. II. The role of the laboratory animal study of intermediate duration for evaluation of safety. Toxicol Appl Pharmacol. 1970 Mar;16(2):498–506. doi: 10.1016/0041-008x(70)90024-4. [DOI] [PubMed] [Google Scholar]
  14. Grice H. C., Munro I. C., Krewski D. R., Munro I. C., Krewski D. R., Blumenthal H. In utero exposure in chronic toxicity/carcinogenicity studies. Food Cosmet Toxicol. 1981 Jun;19(3):373–379. doi: 10.1016/0015-6264(81)90399-0. [DOI] [PubMed] [Google Scholar]
  15. Hicks R. M., Chowaniec J. The importance of synergy between weak carcinogens in the induction of bladder cancer in experimental animals and humans. Cancer Res. 1977 Aug;37(8 Pt 2):2943–2949. [PubMed] [Google Scholar]
  16. Hooson J., Hicks R. M., Grasso P., Chowaniec J. Ortho-toluene sulphonamide and saccharin in the promotion of bladder cancer in the rat. Br J Cancer. 1980 Jul;42(1):129–147. doi: 10.1038/bjc.1980.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kennedy G., Fancher O. E., Calandra J. C. Metabolic fate of saccharin in the albino rat. Food Cosmet Toxicol. 1972 Apr;10(2):143–149. doi: 10.1016/s0015-6264(72)80192-5. [DOI] [PubMed] [Google Scholar]
  18. Kessler I. I. Non-nutritive sweeteners and human bladder cancer: preliminary findings. J Urol. 1976 Feb;115(2):143–146. doi: 10.1016/s0022-5347(17)59104-1. [DOI] [PubMed] [Google Scholar]
  19. Krebs H. A. Inhibition of carbonic anhydrase by sulphonamides. Biochem J. 1948;43(4):525–528. doi: 10.1042/bj0430525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lethco E. J., Wallace W. C. The metabolism of saccharin in animals. Toxicology. 1975;3(3):287–300. doi: 10.1016/0300-483x(75)90030-x. [DOI] [PubMed] [Google Scholar]
  21. Lutz W. K., Schlatter C. Saccharin does not bind to DNA of liver or bladder in the rat. Chem Biol Interact. 1977 Nov;19(2):253–257. doi: 10.1016/0009-2797(77)90036-9. [DOI] [PubMed] [Google Scholar]
  22. Matthews H. B., Fields M., Fishbein L. Saccharin: distribution and excretion of a limited dose in the rat. J Agric Food Chem. 1973 Sep-Oct;21(5):916–919. doi: 10.1021/jf60189a025. [DOI] [PubMed] [Google Scholar]
  23. Miller J. A., Miller E. C. Carcinogens occurring naturally in foods. Fed Proc. 1976 May 1;35(6):1316–1321. [PubMed] [Google Scholar]
  24. Minegishi K. I., Asahina M., Yamaha T. The metabolism of saccharin and the related compounds in rats and guinea pigs. Chem Pharm Bull (Tokyo) 1972 Jul;20(7):1351–1356. doi: 10.1248/cpb.20.1351. [DOI] [PubMed] [Google Scholar]
  25. Morgan R. W., Jain M. G. Bladder cancer: smoking, beverages and artificial sweeteners. Can Med Assoc J. 1974 Nov 16;111(10):1067–1070. [PMC free article] [PubMed] [Google Scholar]
  26. Munro I. C., Moodie C. A., Krewski D., Grice H. C. A carcinogenicity study of commercial saccharin in the rat. Toxicol Appl Pharmacol. 1975 Jun;32(3):513–526. doi: 10.1016/0041-008x(75)90116-7. [DOI] [PubMed] [Google Scholar]
  27. Pitkin R. M., Andersen D. W., Reynolds W. A., Filer L. J., Jr Saccharin metabolism in Macaca mulatta. Proc Soc Exp Biol Med. 1971 Jul;137(3):803–806. doi: 10.3181/00379727-137-35671. [DOI] [PubMed] [Google Scholar]
  28. Pitkin R. M., Reynolds W. A., Filer L. J., Jr, Kling T. G. Placental transmission and fetal distribution of saccharin. Am J Obstet Gynecol. 1971 Sep 15;111(2):280–286. doi: 10.1016/0002-9378(71)90903-3. [DOI] [PubMed] [Google Scholar]
  29. Reuber M. D. Carcinogenicity of saccharin. Environ Health Perspect. 1978 Aug;25:173–200. doi: 10.1289/ehp.7825173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Schmähl D. Fehlen einer kanzerogenen Wirkung von Cyclamat, Cyclohexylamin und Saccharin bei Ratten. Arzneimittelforschung. 1973 Oct;23(10):1466–1470. [PubMed] [Google Scholar]
  31. Stavric B., Lacombe R., Watson J. R., Munro I. C. Isolation, identification, and quantitation of o-toluenesulfonamide, a major impurity in commercial saccharins. J Assoc Off Anal Chem. 1974 May;57(3):678–681. [PubMed] [Google Scholar]
  32. Stavrić B., Klassen R., By A. W. Impurities in commercial saccharin. I. Impurities soluble in organic solvents. J Assoc Off Anal Chem. 1976 Sep;59(5):1051–1058. [PubMed] [Google Scholar]
  33. Sweatman T. W., Renwick A. G. Saccharin metabolism and tumorigenicity. Science. 1979 Sep 7;205(4410):1019–1020. doi: 10.1126/science.472722. [DOI] [PubMed] [Google Scholar]
  34. Sweatman T. W., Renwick A. G. The tissue distribution and pharmacokinetics of saccharin in the rat. Toxicol Appl Pharmacol. 1980 Aug;55(1):18–31. doi: 10.1016/0041-008x(80)90215-x. [DOI] [PubMed] [Google Scholar]
  35. Taylor J. M., Morgenroth V. H., 3rd Comparison of studies on saccharin and sodium nitrite. J Assoc Off Anal Chem. 1979 Jul;62(4):883–888. [PubMed] [Google Scholar]
  36. Taylor J. M., Weinberger M. A., Friedman L. Chronic toxicity and carcinogenicity to the urinary bladder of sodium saccharin in the in utero-exposed rat. Toxicol Appl Pharmacol. 1980 Jun 15;54(1):57–75. doi: 10.1016/0041-008x(80)90008-3. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES